Robin Smith is the founder of ORIG3N. ORIG3N has raised $30M in total funding. Backed by Hatteras Venture Partners, Syno Capital, DEFTA Partners.
Robin Y. Smith is the CEO and co-founder of ORIG3N, Inc., a biotechnology company founded in 2014. ORIG3N focuses on developing treatments for rare and genetically inherited diseases and is involved in regenerative medicine, utilizing a large bank of induced pluripotent stem cells. The company has raised over $30 million in capital, including a $12.5 million Series A round in 2015 and additional funding in 2017.
Full founder directory · Investor directory · Company funding database · Fundraising library